Morrison Research Group



  • Inhibition of RAS Activation Due to a Homozygous Ezrin Variant in Patients with Profound Intellectual Disability.
    Riecken LB, Tawamie H, Dornblut C, Buchert R, Ismayel A, Schulz A, Schumacher J, Sticht H, Pohl KJ, Cui Y, Reis A, Morrison* H, Jamra* RA
    Hum Mutat 2015, 36(2), 270-8 * equal contribution
  • Small GTPase control by ERM proteins and their upstream regulator CPI-17 : implications for tumorigenesis
    Wiehl U
    Dissertation 2015, Jena, Germany
  • Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation.
    Zoch A, Mayerl S, Schulz A, Greither T, Frappart L, Rübsam J, Heuer H, Giovannini M, Morrison H
    PLoS One 2015, 10(8), e0129151
  • Merlin's wizardry guides cohesive migration.
    Zoch A, Morrison H
    Nat Cell Biol 2015, 17(3), 212-3


  • Regulation of the NF2 tumour suppressor Merlin
    Jung J
    Dissertation 2014, Jena, Germany
  • Novel mechanism of JNK pathway activation by adenoviral E1A.
    Romanov* VS, Brichkina* AI, Morrison H, Pospelova TV, Pospelov VA, Herrlich P
    Oncotarget 2014, 5(8), 2176-86 * equal contribution
  • Die Rolle des Tumorsuppressorproteins Merlin bei der Pathogenese von NF2-assoziierter Polyneuropathie
    Schulz A
    Dissertation 2014, Jena, Germany
  • In vivo electrophysiological measurements on mouse sciatic nerves.
    Schulz A, Walther C, Morrison H, Bauer R
    J Vis Exp 2014 Author-Produced Video
  • A neuronal function of the tumor suppressor protein merlin.
    Schulz A, Zoch A, Morrison H
    Acta Neuropathol Commun 2014, 2(1), 82
  • Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling.
    Schulz* A, Kyselyova* A, Baader SL, Jung MJ, Zoch A, Mautner VF, Hagel* C, Morrison* H
    Brain 2014, 137(2), 420-32 * equal contribution